We are proud to welcome Lonnie Shoff as Chair of the Nanophage Technologies Board of Directors.
Lonnie brings more than 30 years of international experience across global healthcare, diagnostics, and life science industries, having held senior leadership positions in some of the industry’s most respected organizations including Roche Diagnostics, Thermo Fisher Scientific, Antech Diagnostics, and Henry Schein.
At Henry Schein she led a diverse investment portfolio of multinational partnerships across the dental, medical, and animal health sectors creating significant value through organic growth and strategic acquisitions. Her distinguished career also includes serving as President of Thermo Fisher’s Clinical Diagnostics Division, President of Antech Diagnostics, and SVP & GM of Roche’s US Molecular Diagnostics and Applied Science Divisions.
With extensive experience in strategic leadership, innovation, and scaling global businesses, Lonnie brings invaluable expertise as Nanophage advances its nanorod technology towards global markets.
Her appointment is an exciting milestone for Nanophage and we are delighted to have someone of Lonnie’s calibre and experience at the helm.